Texas Attorney General Sues Tylenol Manufacturers Regarding Autism Spectrum Claims

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, asserting the corporations concealed potential risks that the pain reliever posed to pediatric brain development.

The lawsuit comes a month after Donald Trump promoted an unproven link between consuming Tylenol - referred to as paracetamol - throughout gestation and autism in offspring.

The attorney general is suing J&J, which formerly manufactured the drug, the sole analgesic suggested for expectant mothers, and Kenvue, which now manufacturers it.

In a official comment, he stated they "deceived the public by gaining financially from discomfort and pushing pills regardless of the dangers."

The company says there is lacking scientific proof connecting Tylenol to autism.

"These manufacturers deceived for years, intentionally threatening millions to increase profits," Paxton, a Republican, said.

The manufacturer stated officially that it was "very worried by the spread of false claims on the security of paracetamol and the potential impact that could have on the well-being of women and children in America."

On its official site, the company also mentioned it had "continuously evaluated the applicable studies and there is lacking reliable evidence that shows a proven link between consuming acetaminophen and autism spectrum disorder."

Associations speaking for doctors and healthcare providers agree.

ACOG has declared acetaminophen - the key substance in Tylenol - is one of the few options for expectant mothers to manage discomfort and fever, which can create significant medical dangers if ignored.

"In over twenty years of research on the use of acetaminophen in gestation, not a single reputable study has successfully concluded that the usage of paracetamol in any period of gestation causes neurodevelopmental disorders in young ones," the organization stated.

This legal action references recent announcements from the Trump administration in claiming the drug is potentially dangerous.

Last month, Trump caused concern from medical authorities when he told pregnant women to "fight like hell" not to take Tylenol when sick.

The FDA then published an announcement that doctors should contemplate reducing the consumption of acetaminophen, while also mentioning that "a proven link" between the medication and autism in young ones has not been established.

The Health Department head Kennedy, who manages the FDA, had pledged in April to undertake "comprehensive study program" that would establish the cause of autism spectrum disorder in a short period.

But experts cautioned that finding a unique factor of autism - considered by experts to be the outcome of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and condition that affects how people encounter and interact with the world, and is diagnosed using doctors' observations.

In his legal document, the attorney general - a Trump ally who is campaigning for US Senate - claims the manufacturer and Johnson & Johnson "intentionally overlooked and sought to suppress the research" around acetaminophen and autism.

The case aims to force the companies "eliminate any promotional materials" that states Tylenol is safe for women during pregnancy.

This legal action echoes the grievances of a group of guardians of minors with autism and ADHD who sued the manufacturers of acetaminophen in 2022.

A federal judge threw out the case, saying studies from the family's specialists was not conclusive.